不论是大股东连续增持亦或是公司持续回购,均彰显其对公司业务发展及未来前景的坚定信心,同时也向市场传递了公司股价被低估的信号。据香港联交所最新股权披露信息显示,近日,康臣药业(01681)获大股东、董事局主席安猛先生持续增持。了解到,安猛先生于今年7月10日和7月11日连续增持康臣药业,合计增持27.80万股,买入均价为11.34港元,彰显大股东对康臣药业未来发展的信心。数据来源:披露易基于对自身“...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.